The St. Petersburg State Institute of Technology (Technical University) invites you to take part in the International conference "Cell Death, Inflammation and Cancer" which will take place on October 29-30, 2015 in the Information center on nuclear energy SPSIT (TU). Organizers of conference are SPSIT (TU) and Cellular Biotechnology laboratory with support of the Ministry of Education and Science of the Russian Federation.
Conference is held within the Resolution No. 220 of the Government of the Russian Federation under the leadership of the leading scientist Martin Seamus.
The leading scientists take part in conference in the field of molecular biology and immunology from Russia, Great Britain, Ireland, Spain, the USA and Canada.
Beatson Institute for Cancer Research, Glasgow, United Kingdom
The aim of our group is to understand the factors regulating programmed cell death in cancer cells. Since it is known that inhibition of cell death mechanisms is a common event in tumour development, this poses problems for many forms of chemotherapy which utilize cell death pathways, leading to drug resistance. We are investigating both known cell death regulators as well as searching for novel proteins that control cell death and chemosensitivity. We envisage that the knowledge gained from our studies will be translated and lead to the improvement of existing clinical regimens or new targets for therapeutic intervention.
Trinity College, Dublin, Ireland
Seamus Martin is the holder of the Smurfit Chair of Medical Genetics at Trinity College Dublin (since 1999). He has an international reputation in the field of programmed cell death (apoptosis), which is highly relevant to cancer and immunity to infectious agents, and is one of the most highly cited scientists in the world on this topic.
University of Rome Tor Vergata, Rome, Italy
Prof G Melino published more than 350 papers crucially contributing to the undersanding of Programmed Cell Death in tumor and epidermis. He focused on p63 and p73 (members of the p53-family of tumor suppressors), showing their role in skin development and tumorigenesis, respectively. Indeed, he discovered a new molecular mechanism responsible for anueploidy (a cause of cancer progression) mediated by p73 interaction with proteins of the kinetochore, which assures accurate chromosomal segregation during mitosis.
Carleton University, Ottawa, Canada
Dr. Brent Derry earned his B.Sc. in Chemistry and Biochemistry at Carleton University (Ottawa, Canada), his M.Sc. in Biochemistry at McMaster University (Hamilton, Canada), and his Ph.D. at the University of California, Santa Barbara (USA). Under the supervision of Dr. Leslie Wilson he elucidated the mechanism of action of the anti-cancer drug Taxol for his Ph.D. thesis.
Bellvitge Biomedical Research Institute, Barcelona, Spain
Cristina Muñoz-Pinedo leads the Cell Death Regulation group at IDIBELL (Bellvitge Biomedical Research Institute) in Barcelona, Spain. She started her scientific career in the field of cell death and cancer metabolism under the supervision of Dr Abelardo López-Rivas at the CSIC, in Granada, Spain. After several short stays in international laboratories she received her PhD from the University of Granada in 2001.
University of Wisconsin, Madison, USA
Eric Baehrecke obtained his Ph.D. from the University of Wisconsin – Madison, and was a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation at the University of Utah during his postdoctoral studies. He was a faculty member of the University of Maryland from 1995-2007, and is currently Professor of the Department of Molecular, Cell and Cancer Biology at the University of Massachusetts Medical School.
Institute of Cytology, St. Petersburg, Russia
Dr Nickolai Barlev gained his PhD in Molecular and Cellular Biology in 1994 at the Institute of Cytology, St. Petersburg, Russia, and the Institute of Molecular Biology, University of Aarhus, Denmark. He then went on to do a Post‐doctoral fellow at the Wistar Institute, Philadelphia, USA, until 1998.
St Petersburg State Institute of Technology, St. Petersburg, Russia
Professor Alexander Garabadzhiu is the Vice-rector for scientific work at the St. Petersburg State Institute of Technology (Technical University). Alexander Garabadzhiu is the known expert in the field of biochemistry for developing medical diagnostic systems. His research area includes toxicity and pathogenic microorganisms. He has developed technological techniques, such as a new class of DNA fluorescent probes, and has worked on retinoids analogous to vitamin A, in which he developed "Adapalen".